| TVTX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TVTX market cap history going back to 11/3/2020:
Also see: TVTX Shares Outstanding History and TVTX YTD Return |
TVTX Market Cap History — Travere Therapeutics Capitalization Over Time
As of 4/30/2026 Travere Therapeutics has a market cap of 3.92 billion. Investors often follow the TVTX market cap history to compare the size of the company over time.
This page shows TVTX market capitalization trends over time, with 21 market cap datapoints presented, dating back to 11/3/2020.
| TVTX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||
TVTX Historical Market Cap: +26.92% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| TVTX Stock Price Chart |
| About Travere Therapeutics Inc |
| Travere Therapeutics, Inc. is a biopharmaceutical company. Co. is focused on identifying, developing, and delivering life-changing therapies to people living with rare kidney and metabolic diseases. Its product, FILSPARI (sparsentan), is indicated to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression. Sparsentan is also in late-stage development for focal segmental glomerulosclerosis (FSGS). Co.'s Pegtibatinase is a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria (HCU), which is a rare metabolic disorder. We show 21 historical shares outstanding datapoints in our TVTX shares outstanding history coverage, used to compute TVTX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TVTX market cap history over the course of time is important for investors interested in comparing TVTX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TVTX versus a peer is one thing; comparing TVTX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TVTX can fluctuate over the course of history. With this page we aim to empower investors researching TVTX by allowing them to research the TVTX market cap history. |
| TVTX Current Stock Quote |
Quotes delayed 20 minutes  Free TVTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| TVTX Share Performance |
| Market Cap Peers |
| Travere Therapeutics (TVTX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
TVTY Market Cap History TWST Market Cap History TXAC Market Cap History TXG Market Cap History TXMD Market Cap History TYME Market Cap History TYRA Market Cap History UBX Market Cap History UFPT Market Cap History UHS Market Cap History More Healthcare companies » |
TVTX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
